PE20030098A1 - Capsulas elasticas blandas y composiciones de las mismas - Google Patents
Capsulas elasticas blandas y composiciones de las mismasInfo
- Publication number
- PE20030098A1 PE20030098A1 PE2002000436A PE2002000436A PE20030098A1 PE 20030098 A1 PE20030098 A1 PE 20030098A1 PE 2002000436 A PE2002000436 A PE 2002000436A PE 2002000436 A PE2002000436 A PE 2002000436A PE 20030098 A1 PE20030098 A1 PE 20030098A1
- Authority
- PE
- Peru
- Prior art keywords
- alcohol
- amino
- filler
- initial state
- agent
- Prior art date
Links
- 239000002775 capsule Substances 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title abstract 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 5
- 239000008177 pharmaceutical agent Substances 0.000 abstract 3
- 239000003795 chemical substances by application Substances 0.000 abstract 2
- 239000011248 coating agent Substances 0.000 abstract 2
- 238000000576 coating method Methods 0.000 abstract 2
- -1 (2-isopropyl-4-thiazolyl) -methyl Chemical group 0.000 abstract 1
- TZFSTJAMNQSGNG-UHFFFAOYSA-N 1,3-thiazol-5-ylmethyl n-(3-hydroxy-1,6-diphenylhexyl)carbamate Chemical compound C=1N=CSC=1COC(=O)NC(C=1C=CC=CC=1)CC(O)CCCC1=CC=CC=C1 TZFSTJAMNQSGNG-UHFFFAOYSA-N 0.000 abstract 1
- 239000001828 Gelatine Substances 0.000 abstract 1
- NCDNCNXCDXHOMX-UHFFFAOYSA-N Ritonavir Natural products C=1C=CC=CC=1CC(NC(=O)OCC=1SC=NC=1)C(O)CC(CC=1C=CC=CC=1)NC(=O)C(C(C)C)NC(=O)N(C)CC1=CSC(C(C)C)=N1 NCDNCNXCDXHOMX-UHFFFAOYSA-N 0.000 abstract 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 abstract 1
- 235000014113 dietary fatty acids Nutrition 0.000 abstract 1
- 229930195729 fatty acid Natural products 0.000 abstract 1
- 239000000194 fatty acid Substances 0.000 abstract 1
- 150000004665 fatty acids Chemical class 0.000 abstract 1
- 229920000159 gelatin Polymers 0.000 abstract 1
- 235000019322 gelatine Nutrition 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- NCDNCNXCDXHOMX-XGKFQTDJSA-N ritonavir Chemical compound N([C@@H](C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](CC=1C=CC=CC=1)NC(=O)OCC=1SC=NC=1)CC=1C=CC=CC=1)C(=O)N(C)CC1=CSC(C(C)C)=N1 NCDNCNXCDXHOMX-XGKFQTDJSA-N 0.000 abstract 1
- 229960000311 ritonavir Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
LA CAPSULA COMPRENDE: I)UN RELLENO, QUE A SU VEZ CONTIENE: i)UN AGENTE O COMBINACION DE AGENTES FARMACEUTICOS, TAL COMO UN INHIBIDOR DE VIH SOLUBILIZADO QUE ES (2S,3S,5S)-5-(N-(N-((N-metil-N-N-((2-isopropil-4-tiazolil)-metil)amino)carbonil)-L-valinil)amino-2-(N-((5-tiazolil)metoxi-carbonil)-amino-1,6-difenil-3-hidroxihexano(ritonavir); ii)UN ALCOHOL; Y, iii)UN ACIDO GRASO; Y II)UN REVESTIMIENTO, QUE A SU VEZ COMPRENDE: 1)GELATINA; Y, 2)POR LO MENOS UN AGENTE PLASTIFICANTE. DONDE (II) TIENE UN ESTADO INICIAL Y UN ESTADO DE EQUILIBRIO; DE MANERA QUE EN EL ESTADO INICIAL SE SUBPLASTIFICA Y (I) CONTIENE UNA CANTIDAD EN EXCESO DE ALCOHOL RESPECTO DE LA CANTIDAD NECESARIA PARA SOLUBILIZAR EL AGENTE FARMACEUTICO Y DICHO ALCOHOL NO ESTA PRESENTE EN EL ESTADO INICIAL DE LA COMPOSICION DE REVESTIMIENTO, Y EN EL ESTADO DE EQUILIBRIO SE PLASTIFICA EL REVESTIMIENTO MEDIANTE EL ALCOHOL PROVENIENTE DEL RELLENO PARA PROPORCIONAR UNA DUREZA DE CAPSULA APROPIADA Y EL RELLENO RETIENE SUFICIENTE ALCOHOL COMO PARA MANTENER AL AGENTE FARMACEUTICO EN SOLUCION
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US86628501A | 2001-05-25 | 2001-05-25 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20030098A1 true PE20030098A1 (es) | 2003-02-12 |
Family
ID=25347294
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2002000436A PE20030098A1 (es) | 2001-05-25 | 2002-05-24 | Capsulas elasticas blandas y composiciones de las mismas |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP1395249A1 (es) |
| JP (1) | JP2005508294A (es) |
| AR (1) | AR034995A1 (es) |
| CA (1) | CA2448438A1 (es) |
| MX (1) | MXPA03010771A (es) |
| PE (1) | PE20030098A1 (es) |
| UY (1) | UY27306A1 (es) |
| WO (1) | WO2002096395A1 (es) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2359945C (en) | 1999-11-12 | 2011-04-26 | Abbott Laboratories | Inhibitors of crystallization in a solid dispersion |
| US7364752B1 (en) | 1999-11-12 | 2008-04-29 | Abbott Laboratories | Solid dispersion pharamaceutical formulations |
| US8025899B2 (en) | 2003-08-28 | 2011-09-27 | Abbott Laboratories | Solid pharmaceutical dosage form |
| KR20150021510A (ko) | 2012-05-03 | 2015-03-02 | 시플라 리미티드 | 항레트로바이러스 조성물 |
| WO2019130341A1 (en) * | 2017-12-26 | 2019-07-04 | Hetero Labs Limited | Capsule compositions comprising lopinavir and ritonavir |
| GB201917252D0 (en) | 2019-11-27 | 2020-01-08 | Pharmaceutic compositions |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA9710071B (en) * | 1996-11-21 | 1998-05-25 | Abbott Lab | Pharmaceutical composition. |
| US6232333B1 (en) * | 1996-11-21 | 2001-05-15 | Abbott Laboratories | Pharmaceutical composition |
| MY121765A (en) * | 1998-07-20 | 2006-02-28 | Abbott Lab | Polymorph of ritonavir |
| SK286305B6 (en) * | 1999-06-04 | 2008-07-07 | Abbott Laboratoires | Improved pharmaceutical formulations comprising ritonavir |
| US6608198B2 (en) * | 2000-03-30 | 2003-08-19 | Abbott Laboratories | Crystalline pharmaceutical |
-
2002
- 2002-05-21 JP JP2002592907A patent/JP2005508294A/ja active Pending
- 2002-05-21 EP EP02737019A patent/EP1395249A1/en not_active Withdrawn
- 2002-05-21 WO PCT/US2002/015955 patent/WO2002096395A1/en not_active Ceased
- 2002-05-21 MX MXPA03010771A patent/MXPA03010771A/es not_active Application Discontinuation
- 2002-05-21 CA CA002448438A patent/CA2448438A1/en not_active Abandoned
- 2002-05-22 AR ARP020101897A patent/AR034995A1/es not_active Application Discontinuation
- 2002-05-24 PE PE2002000436A patent/PE20030098A1/es not_active Application Discontinuation
- 2002-05-24 UY UY27306A patent/UY27306A1/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| UY27306A1 (es) | 2002-12-31 |
| AR034995A1 (es) | 2004-04-14 |
| EP1395249A1 (en) | 2004-03-10 |
| CA2448438A1 (en) | 2002-12-05 |
| MXPA03010771A (es) | 2004-07-01 |
| WO2002096395A1 (en) | 2002-12-05 |
| JP2005508294A (ja) | 2005-03-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2008003491A1 (es) | Composicion farmaceutica en solucion que comprende ritonavir, un solvente organico que comprende un acido graso de cadena larga entre un 30-75% en peso total, agua entre 0,4-3,5% en peso total y opcionalmente un surfactante (divisional de la solicitud 1257-00). | |
| PE20100363A1 (es) | Composiciones que comprenden nucleosidos | |
| PE20241760A1 (es) | Compuestos antivirales que contienen nitrilo | |
| ES2191862T3 (es) | Composicion liquida que comprende un inhibidor de la vih proteasa y un acido graso de c12-c18. | |
| MXPA06008352A (es) | Una composicion farmaceutica. | |
| AR024228A1 (es) | Una composicion farmaceutica que comprende un sensibilizador de insulina y otro agente antidiabetico | |
| UY25055A1 (es) | Formulaciones farmacéuticas que contienen voriconazol | |
| MX9202328A (es) | Composicion farmaceutica local que contiene un compuesto alilamina como el agente activo. | |
| AR027391A1 (es) | Composiciones farmaceuticas de toxina botulinica | |
| ECSP045496A (es) | "preparaciones acidas de insulina con estabilidad mejorada" | |
| BR0316310A (pt) | Composições farmacêuticas tendo um veìculo modificado | |
| AR006598A1 (es) | "composiciones anti-fungosas, su uso en la manufactura de medicamentos y un procedimiento para su preparación" | |
| AR043863A1 (es) | Composiciones que contienen piperacilina y tazobactam, utiles para inyeccioines | |
| DE602004015725D1 (de) | Stabilisierte lyophilisierte zubereitungen mit gewebefaktor-inhibitor (tfpi) oder varianten des gewebefaktor-inhibitors | |
| BR0314450A (pt) | Sais de ácido borÈnico com adição de uma base farmaceuticamente aceitável, formulação farmacêutica, e uso dos referidos sais para preparar uma formulação farmacêutica | |
| ECSP034789A (es) | Composicion parenteral reconstituible que contiene un inhibidor cox-2 ta | |
| ATE202931T1 (de) | Taxanderivate enthaltende arzneizubereitungen | |
| BRPI0410488A (pt) | composição farmacêutica lìquida estabilizada livre de hsa, método para preparação de composição farmacêutica lìquida estabilizada livre de hsa, recipiente vedado hermeticamente e kit para administração de múltiplas doses de composição farmacêutica lìquida estabilizada livre de hsa' | |
| AR051340A1 (es) | Compuesto de c(4)- metoximetil acil pirrolidina, su uso para preparar un medicamento, formulacion farmaceutica que lo comprende y proceso para prepararlo | |
| BR0208727A (pt) | Eritropoietina melhorando a toxicidade in vivo induzida por quimioterapia | |
| GEP20043285B (en) | Sustained Release Beadlets Containing Stavudine, Method for Their Production, Pharmaceutical Composition Containing the Same and Use Thereof for Treatment Retroviral Infections | |
| PE20030098A1 (es) | Capsulas elasticas blandas y composiciones de las mismas | |
| AR049658A2 (es) | Ritonavir amorfo, su uso en la fabricacion de un medicamento, composicion farmaceutica, proceso para su preparacion y proceso para la preparacion de la forma polimorfa cristalina i de ritonavir. | |
| BRPI0418070A (pt) | composição para cuidados pessoais, uso de uma uréia substituìda e método para reduzir a degradação da cor de uma composição para cuidados pessoais | |
| AR040441A1 (es) | Compuesto de tiol, composicion farmaceutica que lo comprende, su uso para la fabricacion de un medicamento, procedimiento para prepararlo y compuesto intermediario de utilidad en dicho procedimiento |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |